Hexafluronium bromide
![]() | |
Clinical data | |
---|---|
ATC code | M03AC05 (WHO) |
Identifiers | |
| |
CAS Number |
317-52-2 ![]() |
PubChem (CID) | 9434 |
DrugBank |
DB00941 ![]() |
ChemSpider |
9063 ![]() |
UNII |
B64NJG83K2 ![]() |
KEGG |
D04435 ![]() |
ECHA InfoCard | 100.005.697 |
Chemical and physical data | |
Formula | C36H42Br2N2 |
Molar mass | 662.54 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Hexafluronium (or hexafluorenium) is a muscle relaxant.[1] It acts as a nicotinic acetylcholine receptor antagonist.
References
- ↑ Baraka A (August 1975). "Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase". Br J Anaesth. 47 (8): 885–8. doi:10.1093/bja/47.8.885. PMID 1201167.
Skeletal muscle relaxants (M03) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Peripherally acting (primarily antinicotinic, NMJ block) |
| ||||||||||||||||
Centrally acting | |||||||||||||||||
Directly acting |
This article is issued from Wikipedia - version of the 10/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.